Cradlewise specializes in developing intelligent infant care devices, particularly a smart crib that adapts to a baby's sleep patterns. This innovative crib can detect the early signs of waking and gently bounces the baby back to sleep, mimicking a parent's soothing touch. In addition to its auto-swinging functionality, the device includes integrated contactless monitoring features that track the baby's posture, activity, and breathing rate. By providing real-time insights, Cradlewise enables parents to better care for their children and reduce the risk of sudden infant death syndrome (SIDS). The company aims to enhance the overall well-being of both infants and their caregivers.
Emys develops customized social robots aimed at teaching foreign languages to children aged 3 to 7 through engaging interactions. These robots are designed to appeal to multiple senses and utilize familiar language, drawing from children's favorite cartoons, toys, and everyday items. Capable of movement, speech, facial recognition, and emotional expression, the robots foster a sense of bonding and companionship, enhancing the language learning experience. Emys combines the expertise of engineers, designers, and educators to integrate robotic technology into children's daily lives. The company has benefited from participation in a prominent hardware startup accelerator and has established operations in Shenzhen, China, to leverage local manufacturing capabilities and technical mentorship. This background supports Emys's mission to create an effective and affordable language learning tool for young children.
AYLIEN Inc. is an artificial intelligence startup based in Wilmington, Delaware, that specializes in natural language processing and content analysis. The company offers a variety of tools designed to help users better understand and analyze human-generated content. Its core products include Text Analysis and News APIs, which assist developers, data scientists, marketers, and academics in processing large volumes of data efficiently. Among its offerings are Talk.ee, which gathers and organizes information, and the AYLIEN App Engine, an open platform for developing micro applications that convert unstructured data into structured formats. Additionally, AYLIEN provides solutions for image recognition and digitizing human preferences through its tool, oTaste. These technologies enable enterprises and developers to extract meaningful insights from text and images, facilitating a deeper understanding of complex data sets.
Microgenesis SA is a biotechnology company focused on developing medical technologies and treatments for reproductive health. Established in 1992 and based in San José de la Rinconada, Spain, the company specializes in non-invasive tests that identify imbalances in vaginal and intestinal microbiota linked to infertility. Additionally, Microgenesis offers dual tests to assess microbiota imbalances related to endometrial immunological issues and provides tools and guidance for managing complex reproductive health cases. Their innovative fertility test and treatment aim to restore fertility potential, particularly for women who have previously experienced multiple IVF failures. Operating from a CLIA-certified lab in Oakland, Microgenesis emphasizes a drug-free, all-natural three-month treatment that addresses subclinical inflammation adversely affecting ovarian function and implantation.
Pregenerate, Inc. is a biotechnology company founded in 2019 and incorporated in Delaware. It specializes in developing scalable organ-on-a-chip models aimed at replacing animal testing in medical and pharmaceutical research, particularly for arthritis treatments. By utilizing human cells in its innovative models, Pregenerate's technology not only enhances the efficiency of drug development but also improves success rates for bringing new medications to market. Furthermore, this approach allows for the stratification of patients into specific treatment subgroups, enabling healthcare providers to tailor therapies to individual needs. This focus on personalized medicine aims to significantly reduce the costs associated with traditional testing methods while advancing the understanding of treatment responses in patients with arthritis.
Maven is a SaaS pet tech startup that provides a personal vet to track the pet’s safety and health 24/7. It focuses on using technology to improve the quality of life for pets, as well as offering pet owners peace of mind and a way to keep track of their pet's safety, health, and well-being on a continual basis through their own personal veterinarian. It was started by the founders of Findster Technologies in 2021 and is based in Porto, Portugal.
Cradlewise specializes in developing intelligent infant care devices, particularly a smart crib that adapts to a baby's sleep patterns. This innovative crib can detect the early signs of waking and gently bounces the baby back to sleep, mimicking a parent's soothing touch. In addition to its auto-swinging functionality, the device includes integrated contactless monitoring features that track the baby's posture, activity, and breathing rate. By providing real-time insights, Cradlewise enables parents to better care for their children and reduce the risk of sudden infant death syndrome (SIDS). The company aims to enhance the overall well-being of both infants and their caregivers.
Microgenesis SA is a biotechnology company focused on developing medical technologies and treatments for reproductive health. Established in 1992 and based in San José de la Rinconada, Spain, the company specializes in non-invasive tests that identify imbalances in vaginal and intestinal microbiota linked to infertility. Additionally, Microgenesis offers dual tests to assess microbiota imbalances related to endometrial immunological issues and provides tools and guidance for managing complex reproductive health cases. Their innovative fertility test and treatment aim to restore fertility potential, particularly for women who have previously experienced multiple IVF failures. Operating from a CLIA-certified lab in Oakland, Microgenesis emphasizes a drug-free, all-natural three-month treatment that addresses subclinical inflammation adversely affecting ovarian function and implantation.
Emys develops customized social robots aimed at teaching foreign languages to children aged 3 to 7 through engaging interactions. These robots are designed to appeal to multiple senses and utilize familiar language, drawing from children's favorite cartoons, toys, and everyday items. Capable of movement, speech, facial recognition, and emotional expression, the robots foster a sense of bonding and companionship, enhancing the language learning experience. Emys combines the expertise of engineers, designers, and educators to integrate robotic technology into children's daily lives. The company has benefited from participation in a prominent hardware startup accelerator and has established operations in Shenzhen, China, to leverage local manufacturing capabilities and technical mentorship. This background supports Emys's mission to create an effective and affordable language learning tool for young children.
Pregenerate, Inc. is a biotechnology company founded in 2019 and incorporated in Delaware. It specializes in developing scalable organ-on-a-chip models aimed at replacing animal testing in medical and pharmaceutical research, particularly for arthritis treatments. By utilizing human cells in its innovative models, Pregenerate's technology not only enhances the efficiency of drug development but also improves success rates for bringing new medications to market. Furthermore, this approach allows for the stratification of patients into specific treatment subgroups, enabling healthcare providers to tailor therapies to individual needs. This focus on personalized medicine aims to significantly reduce the costs associated with traditional testing methods while advancing the understanding of treatment responses in patients with arthritis.
Microgenesis SA is a biotechnology company focused on developing medical technologies and treatments for reproductive health. Established in 1992 and based in San José de la Rinconada, Spain, the company specializes in non-invasive tests that identify imbalances in vaginal and intestinal microbiota linked to infertility. Additionally, Microgenesis offers dual tests to assess microbiota imbalances related to endometrial immunological issues and provides tools and guidance for managing complex reproductive health cases. Their innovative fertility test and treatment aim to restore fertility potential, particularly for women who have previously experienced multiple IVF failures. Operating from a CLIA-certified lab in Oakland, Microgenesis emphasizes a drug-free, all-natural three-month treatment that addresses subclinical inflammation adversely affecting ovarian function and implantation.
Microgenesis SA is a biotechnology company focused on developing medical technologies and treatments for reproductive health. Established in 1992 and based in San José de la Rinconada, Spain, the company specializes in non-invasive tests that identify imbalances in vaginal and intestinal microbiota linked to infertility. Additionally, Microgenesis offers dual tests to assess microbiota imbalances related to endometrial immunological issues and provides tools and guidance for managing complex reproductive health cases. Their innovative fertility test and treatment aim to restore fertility potential, particularly for women who have previously experienced multiple IVF failures. Operating from a CLIA-certified lab in Oakland, Microgenesis emphasizes a drug-free, all-natural three-month treatment that addresses subclinical inflammation adversely affecting ovarian function and implantation.
Emys develops customized social robots aimed at teaching foreign languages to children aged 3 to 7 through engaging interactions. These robots are designed to appeal to multiple senses and utilize familiar language, drawing from children's favorite cartoons, toys, and everyday items. Capable of movement, speech, facial recognition, and emotional expression, the robots foster a sense of bonding and companionship, enhancing the language learning experience. Emys combines the expertise of engineers, designers, and educators to integrate robotic technology into children's daily lives. The company has benefited from participation in a prominent hardware startup accelerator and has established operations in Shenzhen, China, to leverage local manufacturing capabilities and technical mentorship. This background supports Emys's mission to create an effective and affordable language learning tool for young children.
AYLIEN Inc. is an artificial intelligence startup based in Wilmington, Delaware, that specializes in natural language processing and content analysis. The company offers a variety of tools designed to help users better understand and analyze human-generated content. Its core products include Text Analysis and News APIs, which assist developers, data scientists, marketers, and academics in processing large volumes of data efficiently. Among its offerings are Talk.ee, which gathers and organizes information, and the AYLIEN App Engine, an open platform for developing micro applications that convert unstructured data into structured formats. Additionally, AYLIEN provides solutions for image recognition and digitizing human preferences through its tool, oTaste. These technologies enable enterprises and developers to extract meaningful insights from text and images, facilitating a deeper understanding of complex data sets.
Cradlewise specializes in developing intelligent infant care devices, particularly a smart crib that adapts to a baby's sleep patterns. This innovative crib can detect the early signs of waking and gently bounces the baby back to sleep, mimicking a parent's soothing touch. In addition to its auto-swinging functionality, the device includes integrated contactless monitoring features that track the baby's posture, activity, and breathing rate. By providing real-time insights, Cradlewise enables parents to better care for their children and reduce the risk of sudden infant death syndrome (SIDS). The company aims to enhance the overall well-being of both infants and their caregivers.
CyCa OncoSolutions Pvt. Ltd. specializes in the development of molecular devices designed for the programmable delivery of anticancer drugs directly into cells. The company has created a novel drug delivery system that effectively crosses cellular membrane bilayers, enabling the transport of functional molecules such as anticancer agents, water-soluble dyes, and imaging agents into the cytoplasm or other cellular organelles. This technology is particularly beneficial for pharmaceutical and biotechnology companies, as it enhances the brand lifecycle of their drugs and molecules. Founded in 2017, CyCa OncoSolutions is headquartered in Balasore, India.
Cradlewise specializes in developing intelligent infant care devices, particularly a smart crib that adapts to a baby's sleep patterns. This innovative crib can detect the early signs of waking and gently bounces the baby back to sleep, mimicking a parent's soothing touch. In addition to its auto-swinging functionality, the device includes integrated contactless monitoring features that track the baby's posture, activity, and breathing rate. By providing real-time insights, Cradlewise enables parents to better care for their children and reduce the risk of sudden infant death syndrome (SIDS). The company aims to enhance the overall well-being of both infants and their caregivers.
Bioptamers, Inc. specializes in the development of cellular and gene therapies aimed at treating cancer. Founded in 2018 and headquartered in New Castle, Delaware, with an additional office in São Paulo, Brazil, the company focuses on innovative therapeutic delivery technologies using monoclonal antibodies and antibody-drug conjugates. Bioptamers is creating a platform to optimize aptamer selection, allowing for personalized cancer therapy tailored to individual patient needs. The company aims to transform these specialized molecules into valuable clinical products, which will be licensed to pharmaceutical companies for further development and commercialization.
Orenda makes coffee machine on the market by tailoring the brewing process to your unique taste profile and the beans you use.
Pregenerate, Inc. is a biotechnology company founded in 2019 and incorporated in Delaware. It specializes in developing scalable organ-on-a-chip models aimed at replacing animal testing in medical and pharmaceutical research, particularly for arthritis treatments. By utilizing human cells in its innovative models, Pregenerate's technology not only enhances the efficiency of drug development but also improves success rates for bringing new medications to market. Furthermore, this approach allows for the stratification of patients into specific treatment subgroups, enabling healthcare providers to tailor therapies to individual needs. This focus on personalized medicine aims to significantly reduce the costs associated with traditional testing methods while advancing the understanding of treatment responses in patients with arthritis.
Emys develops customized social robots aimed at teaching foreign languages to children aged 3 to 7 through engaging interactions. These robots are designed to appeal to multiple senses and utilize familiar language, drawing from children's favorite cartoons, toys, and everyday items. Capable of movement, speech, facial recognition, and emotional expression, the robots foster a sense of bonding and companionship, enhancing the language learning experience. Emys combines the expertise of engineers, designers, and educators to integrate robotic technology into children's daily lives. The company has benefited from participation in a prominent hardware startup accelerator and has established operations in Shenzhen, China, to leverage local manufacturing capabilities and technical mentorship. This background supports Emys's mission to create an effective and affordable language learning tool for young children.
Orenda makes coffee machine on the market by tailoring the brewing process to your unique taste profile and the beans you use.
CyCa OncoSolutions Pvt. Ltd. specializes in the development of molecular devices designed for the programmable delivery of anticancer drugs directly into cells. The company has created a novel drug delivery system that effectively crosses cellular membrane bilayers, enabling the transport of functional molecules such as anticancer agents, water-soluble dyes, and imaging agents into the cytoplasm or other cellular organelles. This technology is particularly beneficial for pharmaceutical and biotechnology companies, as it enhances the brand lifecycle of their drugs and molecules. Founded in 2017, CyCa OncoSolutions is headquartered in Balasore, India.
Orenda makes coffee machine on the market by tailoring the brewing process to your unique taste profile and the beans you use.
AYLIEN Inc. is an artificial intelligence startup based in Wilmington, Delaware, that specializes in natural language processing and content analysis. The company offers a variety of tools designed to help users better understand and analyze human-generated content. Its core products include Text Analysis and News APIs, which assist developers, data scientists, marketers, and academics in processing large volumes of data efficiently. Among its offerings are Talk.ee, which gathers and organizes information, and the AYLIEN App Engine, an open platform for developing micro applications that convert unstructured data into structured formats. Additionally, AYLIEN provides solutions for image recognition and digitizing human preferences through its tool, oTaste. These technologies enable enterprises and developers to extract meaningful insights from text and images, facilitating a deeper understanding of complex data sets.
CyCa OncoSolutions Pvt. Ltd. specializes in the development of molecular devices designed for the programmable delivery of anticancer drugs directly into cells. The company has created a novel drug delivery system that effectively crosses cellular membrane bilayers, enabling the transport of functional molecules such as anticancer agents, water-soluble dyes, and imaging agents into the cytoplasm or other cellular organelles. This technology is particularly beneficial for pharmaceutical and biotechnology companies, as it enhances the brand lifecycle of their drugs and molecules. Founded in 2017, CyCa OncoSolutions is headquartered in Balasore, India.
Emys develops customized social robots aimed at teaching foreign languages to children aged 3 to 7 through engaging interactions. These robots are designed to appeal to multiple senses and utilize familiar language, drawing from children's favorite cartoons, toys, and everyday items. Capable of movement, speech, facial recognition, and emotional expression, the robots foster a sense of bonding and companionship, enhancing the language learning experience. Emys combines the expertise of engineers, designers, and educators to integrate robotic technology into children's daily lives. The company has benefited from participation in a prominent hardware startup accelerator and has established operations in Shenzhen, China, to leverage local manufacturing capabilities and technical mentorship. This background supports Emys's mission to create an effective and affordable language learning tool for young children.
Emys develops customized social robots aimed at teaching foreign languages to children aged 3 to 7 through engaging interactions. These robots are designed to appeal to multiple senses and utilize familiar language, drawing from children's favorite cartoons, toys, and everyday items. Capable of movement, speech, facial recognition, and emotional expression, the robots foster a sense of bonding and companionship, enhancing the language learning experience. Emys combines the expertise of engineers, designers, and educators to integrate robotic technology into children's daily lives. The company has benefited from participation in a prominent hardware startup accelerator and has established operations in Shenzhen, China, to leverage local manufacturing capabilities and technical mentorship. This background supports Emys's mission to create an effective and affordable language learning tool for young children.
AYLIEN Inc. is an artificial intelligence startup based in Wilmington, Delaware, that specializes in natural language processing and content analysis. The company offers a variety of tools designed to help users better understand and analyze human-generated content. Its core products include Text Analysis and News APIs, which assist developers, data scientists, marketers, and academics in processing large volumes of data efficiently. Among its offerings are Talk.ee, which gathers and organizes information, and the AYLIEN App Engine, an open platform for developing micro applications that convert unstructured data into structured formats. Additionally, AYLIEN provides solutions for image recognition and digitizing human preferences through its tool, oTaste. These technologies enable enterprises and developers to extract meaningful insights from text and images, facilitating a deeper understanding of complex data sets.
Orenda makes coffee machine on the market by tailoring the brewing process to your unique taste profile and the beans you use.
Orenda makes coffee machine on the market by tailoring the brewing process to your unique taste profile and the beans you use.
AYLIEN Inc. is an artificial intelligence startup based in Wilmington, Delaware, that specializes in natural language processing and content analysis. The company offers a variety of tools designed to help users better understand and analyze human-generated content. Its core products include Text Analysis and News APIs, which assist developers, data scientists, marketers, and academics in processing large volumes of data efficiently. Among its offerings are Talk.ee, which gathers and organizes information, and the AYLIEN App Engine, an open platform for developing micro applications that convert unstructured data into structured formats. Additionally, AYLIEN provides solutions for image recognition and digitizing human preferences through its tool, oTaste. These technologies enable enterprises and developers to extract meaningful insights from text and images, facilitating a deeper understanding of complex data sets.
AYLIEN Inc. is an artificial intelligence startup based in Wilmington, Delaware, that specializes in natural language processing and content analysis. The company offers a variety of tools designed to help users better understand and analyze human-generated content. Its core products include Text Analysis and News APIs, which assist developers, data scientists, marketers, and academics in processing large volumes of data efficiently. Among its offerings are Talk.ee, which gathers and organizes information, and the AYLIEN App Engine, an open platform for developing micro applications that convert unstructured data into structured formats. Additionally, AYLIEN provides solutions for image recognition and digitizing human preferences through its tool, oTaste. These technologies enable enterprises and developers to extract meaningful insights from text and images, facilitating a deeper understanding of complex data sets.